Other antigout drugs
Allopurinol is used to reduce production of uric acid,
preventinggouty attacks, and colchicine
is used to treat acute gouty attacks.
Allopurinol and colchicine take somewhat different
paths through the body.
When given orally, allopurinol is absorbed from the
GI tract. Allo-purinol and its metabolite oxypurinol are distributed throughout
the body except in the brain, where drug concentrations are 50% of those found in the rest of the body. It’s
metabolized by the liver and excreted in urine.
Colchicine is absorbed from the GI tract and is
partially metabo-lized in the liver. The drug and its metabolites then reenter
the in-testinal tract through biliary secretions. After reabsorption from the
intestines, colchicine is distributed to various tissues. It’s ex-creted
primarily in stool and to a lesser degree in urine.
Allopurinol and its metabolite oxypurinol inhibit
xanthine oxi-dase, the enzyme responsible for the production of uric acid. By
reducing uric acid formation, allopurinol eliminates the hazards of
hyperuricuria.
Colchicine appears to reduce the inflammatory
response to mono-sodium urate crystals deposited in joint tissues. Colchicine
may produce its effects by inhibiting migration of white blood cells (WBCs) to
the inflamed joint. This reduces phagocytosis and lac-tic acid production by
WBCs, decreasing urate crystal deposits and reducing inflammation.
Allopurinol treats primary gout, hopefully preventing
acute gouty attacks. It can be prescribed with uricosurics when smaller dosages
of each drug are directed. It’s used to treat:
§ gout or hyperuricemia that may occur with
blood abnormalities and during treatment of tumors or leukemia
§ primary or secondary uric acid nephropathy
(with or without the accompanying symptoms of gout)
§ patients who respond poorly to maximum
dosages of urico-surics or who have allergic reactions or intolerance to
uricosuric drugs (it’s also used to prevent recurrent uric acid stone
forma-tion).
Colchicine is used to relieve the inflammation of
acute gouty arthritis attacks. If given promptly, it’s especially effective in
re-lieving pain. In addition, giving colchicine during the first several months
of allopurinol, probenecid, or sulfinpyrazone therapy may prevent the acute
gouty attacks that sometimes accompany the use of these drugs.
Colchicine doesn’t interact significantly with
other drugs. When allopurinol is used with other drugs, the resulting
interactions can be serious:
·
Allopurinol potentiates the effect of oral anticoagulants.
·
Allopurinol increases the serum concentrations of mercapto-purine and
azathioprine, increasing the risk of toxicity.
·
Angiotensin-converting enzyme inhibitors increase the risk of
hypersensitivity reactions to allopurinol.
·
Allopurinol increases serum theophylline levels.
·
The risk of bone marrow depression increases when cyclophos-phamide is
taken with allopurinol. (See Adverse
reactions to otherantigout drugs.)
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.